In MS patients presenting with clinical symptoms such as systemic arterial hypertension, dyslipidemia, obesity, and increased abdominal circumference, there is a marked upregulation of CAV-1 mRNA expression [1]. The gene discussed is CAV1; the disease is metabolic syndrome.